These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 8353228)

  • 1. Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome.
    Mishu B; Blaser MJ
    Clin Infect Dis; 1993 Jul; 17(1):104-8. PubMed ID: 8353228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Campylobacter infection and Guillain-Barré syndrome.
    Allos BM
    J Infect Dis; 1997 Dec; 176 Suppl 2():S125-8. PubMed ID: 9396695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Campylobacter jejuni infection as a cause of the Guillain-Barré syndrome.
    Allos BM
    Infect Dis Clin North Am; 1998 Mar; 12(1):173-84. PubMed ID: 9494837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
    Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
    Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter jejuni strains from patients with Guillain-Barré syndrome.
    Allos BM; Lippy FT; Carlsen A; Washburn RG; Blaser MJ
    Emerg Infect Dis; 1998; 4(2):263-8. PubMed ID: 9621196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
    Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
    Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibody level against GroEL type heat-shock protein of Campylobacter jejuni in patients with Guillain-Barré syndrome.
    Fujimoto S; Fujita M
    Microbiol Immunol; 1999; 43(3):241-4. PubMed ID: 10338193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campylobacter jejuni and Guillain-Barré syndrome.
    Rees JH; Gregson NA; Griffiths PL; Hughes RA
    Q J Med; 1993 Oct; 86(10):623-34. PubMed ID: 8255960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case control study in a tertiary care hospital.
    Sharma A; Lal V; Modi M; Vaishnavi C; Prabhakar S
    Neurol India; 2011; 59(5):717-21. PubMed ID: 22019657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a renal transplant recipient.
    Maccario M; Tarantino A; Nobile-Orazio E; Ponticelli C
    Transpl Int; 1998; 11(6):439-42. PubMed ID: 9870273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Campylobacter jejuni infection and Guillain-Barré syndrome.
    Rees JH; Soudain SE; Gregson NA; Hughes RA
    N Engl J Med; 1995 Nov; 333(21):1374-9. PubMed ID: 7477117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The demyelination neurophysiological criteria can be misleading in Campylobacter jejuni-related Guillain-Barré syndrome.
    Kokubun N; Shahrizaila N; Koga M; Hirata K; Yuki N
    Clin Neurophysiol; 2013 Aug; 124(8):1671-9. PubMed ID: 23514735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
    Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
    Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
    Hagensee ME; Benyunes M; Miller JA; Spach DH
    Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome subtypes related to Campylobacter infection.
    Drenthen J; Yuki N; Meulstee J; Maathuis EM; van Doorn PA; Visser GH; Blok JH; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):300-5. PubMed ID: 21270063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiologic approaches for studying Campylobacter species in patients with Guillain-Barré syndrome.
    Nachamkin I
    J Infect Dis; 1997 Dec; 176 Suppl 2():S106-14. PubMed ID: 9396692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000-2001.
    Tam CC; Rodrigues LC; O'Brien SJ
    Clin Infect Dis; 2003 Jul; 37(2):307-10. PubMed ID: 12856224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and epidemiologic features of Guillain-Barré syndrome.
    Hughes RA; Rees JH
    J Infect Dis; 1997 Dec; 176 Suppl 2():S92-8. PubMed ID: 9396689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.